Featured Posts

ATR Submits Comments Urging USITC to Recommend Against TRIPS Waiver Expansion
Last week, Americans for Tax Reform and the Property Rights Alliance submitted respective comments to the United States International Trade Commission (USITC) urging the agency…
Commentary

ATR Joins Coalition in Support of Site-Neutral Payments
Today, Americans for Tax Reform joined a coalition letter in support of site-neutral payments and service billing transparency in commercial health insurance. The letter,…
Commentary

S.127 Would Increase the Deficit by Tens of Billions of Dollars
Today, the Senate Commerce Committee will hold an executive session considering S. 127, the Pharmacy Benefit Manager Transparency Act (PBMTA), legislation that was recently re-introduced by…
Commentary
Filtered Posts

Biden Budget Expands Disastrous Price Controls on Medicine
Commentary

Sen. Cruz is Right to Urge Caution on Giving FTC New Power to Regulate
Commentary

Senate Should Reject S. 150, Legislation That Would Stunt Medical Innovation
Commentary

Even Before Implementation, Democrats’ Price Control Policies are Inhibiting Medical Innovation
Commentary

ATR Supports Senator Lee’s Bill to Roll Back Biden’s Drug Price Controls
Commentary

Poll: Canadians Significantly Less Confident in Their Healthcare System Than Americans
Commentary

STUDY: Drug Price Controls Will Actually Raise Health Costs
Commentary

Drug Price Controls Will Cost Lives, Not Save Them
Commentary

Biden Isn’t “Negotiating” Drug Prices, He’s Forcing Price Controls Through Tax Hikes
Commentary

Expanding Obamacare Subsidies Will Make Inflation Worse
Commentary